High-quality products
Reliable performance
Alogliptin decreases the incretin glucose dependent insulinotropic polypeptide (GIP) and glucagon like peptide (GLP-2). increases the plasma incretin concentration, which can controls the glucose levels in the blood. GIP and GLP-2 are stimulating the glucose dependent pancreatic beta cells. It inhibits the activity of GIP and GLP-2.
High-quality products
Reliable performance
Wide range of applications
For various laboratory needs
Expert support
Professional service team
Fast delivery
Global shipping